Based on these results, it may be suggestive to provide the therapies or molecules which may assist in maximum structural restoration of the mutated SOD1 protein to provide the interactive interface for downstream molecules, may be beneficial for ALS patients. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.